What Sets Us Apart

CEO NOMINATED FOR WOMEN OF INFLUENCE

Linda Moore Schipani, RN, MSN, president and CEO of Clinical Research Associates, was nominated for Nashville Business Journal's 2013 Women of Influence. Forbes Magazine profile Schipani and Clinical Research Associates and its 23-year history of "bringing medical breakthroughs to market." Read the Forbes article here.

GOOD NEWS FROM A RECENT TRIAL

Clinical Research Associates recently conducted a clinical trial on Zostavax. This is a vaccine to prevent shingles. Formerly, Zostavax was approved only for those 60 and up. We wanted to let our participants know that Zostavax is now approved by FDA for ages 50 and up. This shows the real-world difference that clinical trials can make!

CLINICAL RESEARCH ASSOCIATES' DR. GREG KYSER HONORED

Dr. Greg Kyser, a Nashville psychiatrist and staff physician with Clinical Research Associates, was honored by the American Psychiatric Association (APA) in March with the Warren Williams Assembly Award. Established in 1984, this award is administered by the APA Area Councils to recognize outstanding recent or current contributions in the field of psychiatry.The nomination was based on Dr. Kyser’s tireless advocacy efforts on behalf of Tennessee Psychiatric Association, the state’s leading professional organization on behavioral health.

HOW MUCH DO YOU KNOW ABOUT VACCINES?

There is a great deal of misinformation and fear out there about vaccines. According to a recent study, less than half of all Americans got a flu shot last year. The Centers for Disease Control (CDC) strongly recommends annual flu shots. Read the story. How much do you really understand about vaccines? Arm yourself with the medical truth about vaccines. Read more. 

DR. STEPHAN SHARP NAMED HEALTHCARE HERO BY NASHVILLE BUSINESS JOURNAL

Clinical Research Associates' Medical Director, Dr. Stephan Sharp, was named to the list of Healthcare Heroes by the publication. Read the full Nashville Business Journal here.